ShardaCare-Healthcity has launched North India’s largest Bone Marrow Transplant (BMT) Centre, marking a significant milestone in advanced tertiary care in the region.
The centre was formally inaugurated by Hon’ble Deputy Chief Minister and Minister of Health & Family Welfare, Uttar Pradesh, Shri Brajesh Pathak, in the presence of distinguished dignitaries, medical experts, and leadership from Sharda Group.
The centre will provide comprehensive bone marrow transplant services for both pediatric and adult patients, including matched sibling, matched unrelated donor, and haploidentical transplants. It will also offer autologous BMT for autoimmune conditions, particularly multiple sclerosis, backed by high-dose and induction therapies, targeted treatments, immunotherapies, advanced graft manipulation, and CAR-T cell therapy. Equipped with dedicated HEPA-filtered transplant units for strict infection control, the centre also offers advanced diagnostics and immunology support for accurate donor matching and close monitoring. With expertise across autologous, allogeneic, and haploidentical transplants, along with integrated critical care, oncology, and hematology services under one roof, the facility is designed to deliver safe, seamless, and patient-centric care focused on better outcomes and recovery. What distinguishes ShardaCare-Healthcity’s BMT Centre is its scale, robust clinical protocols, and ability to provide end-to-end transplant care within a single integrated ecosystem, making advanced transplant services more accessible while reducing dependence on metro cities. A large number of adults continue to remain undiagnosed or live with long-term complications due to late detection. Among children, the challenge is equally concerning, with more than one in four aged 0 to 12 years suspected of having a blood disorder being diagnosed with inherited haemoglobin diseases and over half of them are below the age of three.
Speaking on the occasion, Mr. P.K. Gupta, Chairman, Sharda Group, said: “The launch of Bone Marrow Transplant centre reflects our commitment to making highly specialized, life-saving treatments like BMT accessible at scale, while setting new benchmarks in clinical excellence and patient care.”
Mr. Y.K. Gupta, Vice Chairman, Sharda Group, added: “The establishment of this advanced BMT Centre strengthens ShardaCare Healthcity’s position as a leader in tertiary care. By combining cutting-edge technology with expert medical teams, we aim to deliver superior transplant outcomes and bring world-class hematology care closer to patients across North India.”
Highlighting the clinical excellence and larger healthcare vision Dr. Pawan Kumar Singh, Vice Chairman, Department of Haemato-Oncology & BMT, ShardaCare-Healthcity, said: ” At ShardaCare- Healthcity, we are not only advancing BMT services with precision, safety, and improved outcomes, but also actively supporting the Government of India’s mission to eliminate sickle cell disease by 2047 through comprehensive and curative care. Our focus is to expand access, enhance outcomes, and bring hope to patients and families.”
With this launch, ShardaCare-Healthcity further cements its position as a leading healthcare destination in North India: combining scale, expertise, and innovation. As the largest hospital in Greater Noida and now home to the region’s largest BMT Centre, it continues to redefine standards in patient care and clinical excellence.
